Clinical Trial Update: Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection

View source ↗

Summary

This document provides an update on Verici Dx’s clinical trial validating genomic immune-phenotyping profiles to predict the risk of kidney transplant rejection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Snippet

Sponsor: Verici Dx | Conditions: Kidney Transplant Rejection | Status: ACTIVE_NOT_RECRUITING